title: [Main principles and IVF-ET results of the centre for assisted reproduction "Varna", Bulgaria].
abstract: The authors formulate the main principles of IVF-ET, based on personal experience i.e. hormonal ovarian stimulation, ovarian puncture, fertilization and ET, prophylaxis and therapy of early complications. Clinical pregnancy was achieved in 287 of 612 patients (43.9% per cycle and 46.9% per transfer). The cancellation rate is 9.6% (42 patients), the miscarriage rate is 14.2% (41 patients). In three cases the pregnancy was ectopic. The multiple pregnancy rate is 32.7% (94 cases): 84 bigemini, 9 trigemini and 1 quadrigemini. In 2006 the multiple pregnancy rate was reduced to 28%. The mean number of transferred embryos was 3.2 and in 2006--2.8; 80.5% of the pregnant women were under 35 years of age. Severe complications occurred in 16 cases--2.6%: OHSS in 15 cases and one with massive intraabdominal hemorrhage from ruptured ovaries. In conclusion the authors stressed the necessity of undelayed resort to ART treatment. Hydrosalpinxes have to be removed preliminarily and partial resection of the ovaries should be done only in rare cases. In Bulgaria at least 6000 fully reimbursed IVF-ICSI procedures yearly ought to be done because of the considerable rate of the inflammatory female and male infertility.
authors.forename: I
authors.initials: I
authors.lastname: Kozovski
authors.forename: K
authors.initials: K
authors.lastname: Markova
authors.forename: K
authors.initials: K
authors.lastname: Aleksandrov
authors.forename: S
authors.initials: S
authors.lastname: Cherneva
authors.forename: G
authors.initials: G
authors.lastname: Kozovski
authors.forename: E
authors.initials: E
authors.lastname: Kovachev
mesh_terms: D000046:Academic Medical Centers; D002031:Bulgaria; D004624:Embryo Transfer / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005307:Fertilization in Vitro / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007247:Infertility, Female / Q000628:therapy*; D007248:Infertility, Male / Q000628:therapy*; D008297:Male; D008423:Maternal Age; D011247:Pregnancy; D020554:Sperm Injections, Intracytoplasmic / Q000009:adverse effects / Q000379:methods